email@mymsaa.org
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Improving Lives Today!
donate
About MS
MS Overview
Newly Diagnosed
Symptoms
Treatments
Online Webinars & Videos
MSAA Publications
Prescription Assistance Programs
Toll-Free Helpline
Clinical Trial Information
Información en Español
FAQs



Home > About MS > Clinical Trials Resource Center


Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine

Multiple Sclerosis Clinical Trials


A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Investigational Site Number 840077 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Birmingham : Alabama Neurology Associates

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Birmingham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Birmingham : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Birmingham : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cullman : Investigational Site Number 840004 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Cullman : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cullman : Teva Investigational Site 10329

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cullman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Arizona

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Gilbert : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Gilbert : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Glendale : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Phoenix : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Phoenix : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Phoenix : Investigational Site Number 840114 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Phoenix : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix : Receptos Study Site 118 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Phoenix : Receptos Study Site 115 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Phoenix : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Scottsdale : Investigational Site Number 840080 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tempe : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tucson : NSS Clinical Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Tucson : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Tucson : Northwest NeuroSpecialists, PLLC

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tucson : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tucson : Receptos Study Site 119 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Tucson : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson : NSS Clinical Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tucson : Northwest NeuroSpecialists, PLLC

Patients are needed to participate in a clinical research study of MSDX Complex-1 Biomarker test to evaluate Relapsing Remitting Multiple Sclerosis

Arkansas

Phoenix : Investigational Site Number 840021 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

California

Berkeley : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Berkeley : Receptos Study Site 110 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Davis : University of California Davis

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Fresno : Victoria Walton, MD

A clinical study for patients with Multiple Sclerosis

Fresno :

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis or Urinary Bladder Diseases

Fresno : Teva Investigational Site 10310

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fullerton : Fullerton Neurology and Headache Center

A clinical study for patients with Multiple Sclerosis

Fullerton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

La Jolla : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

La Jolla : StemGenex

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis

Long Beach : Collaborative Neuroscience Network, Inc.

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Long Beach : Receptos Study Site 122 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Los Angeles : Sanguine Biosciences

A clinical study for patients with Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease or Huntington's Disease

Los Angeles : Keck School of Medicine of the University of Southern Calfornia

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Los Angeles : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Los Angeles : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Los Angeles : Univeristy of California Los Angeles

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Newport Beach : Multiple Sclerosis Center of California & Research

A clinical study for patients with Multiple Sclerosis

Newport Beach : Investigational Site Number 840014 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Newport Beach : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport Beach : MS Center of California

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oceanside : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Sacramento : Sutter Institute for Medical Research

A clinical study for patients with Multiple Sclerosis

Sacramento : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Sacramento : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Sacramento : Receptos Study Site 112 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sacramento : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Diego : Pacific Research Network Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

San Diego : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

San Diego : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

San Francisco : University of California San Francisco

A clinical study for patients with Multiple Sclerosis

San Francisco : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

San Francisco : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

San Francisco : Receptos Study Site 120 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Temecula : Viking Clinical Research Center

A clinical study for patients with Multiple Sclerosis

Torrance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Torrance : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Colorado

Boulder : Alpine Clinical Research Center

Investigational Medication for people with Relapsing Remitting Multiple Sclerosis

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS)

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS) who have had a documented relapse in the last year

Boulder : Alpine Clinical Research Center

New Investigational Medication for Secondary Progressive Multiple Sclerosis

Boulder : Alpine Clinical Research Center

Newly Approved Medication for Multiple Sclerosis

Aurora : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Aurora : University of Colorado Denver

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Aurora : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Aurora : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Aurora : Teva Investigational Site 10307

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Aurora : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Basalt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Boulder : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Boulder : Investigational Site Number 840097 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Boulder : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Centennial : Investigational Site Number 840006 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Colorado Springs : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Denver : Investigational Site Number 840046 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Denver : Mountain View Clinical Research, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Denver : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Denver : University of Colorado Denver

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Englewood : Colorado Neurological Institute

A clinical study for patients with Multiple Sclerosis

Englewood : Investigational Site Number 840016 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Englewood : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Englewood : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Fort Collins : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Fort Collins : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Fort Collins : Investigational Site Number 840005 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Fort Collins : Teva Investigational Site 10332

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fort Collins : Advanced Neurosciences Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Fort Collins : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Connecticut

Danbury : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Danbury : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Derby : Multiple Sclerosis Treatment Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Derby : Multiple Sclerosis Treatment Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Fairfield : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Fairfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Hartford : The Mandell Center for Multiple Sclerosis

Patients are needed to participate in a clinical research study evaluating Avonex for the treatment of Multiple Sclerosis

New Haven : Institute for Neurodegenerative Disorders

Patients are needed to participate in a clinical research study of [18F]Florbetapir and PET imaging to evaluate Multiple Sclerosis

New London : Coastal Connecticute Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

New London : Coastal Connecticute Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Delaware

Dover : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Dover : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Dover : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Newark : Christiana Care Health Services

A clinical study for patients with Multiple Sclerosis

Newark : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Newark : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

District of Columbia

Washington : Georgetown University Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Washington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Washington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Washington : Georgetown University Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Washington : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Florida

Tampa : Axiom Clinical Research of Florida

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis

Tampa : Axiom Clinical Research of Florida

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

Tampa : Axiom Clinical Research of Florida

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Oral Multiple Sclerosis Medication Study

Bradenton : Brandenton Neurology, Inc.

A clinical study for patients with Multiple Sclerosis

Bradenton : Bradenton Research Center, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Bradenton : Bradenton Research Center, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Clearwater : Investigational Site Number 840089 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Delray Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gainesville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Hollywood : Sunrise Clinical Research, Inc.

A clinical study for patients with Multiple Sclerosis

Jacksonville : University of Florida

A clinical study for patients with Multiple Sclerosis

Jacksonville : Jacksonville Center For Clinical Research

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Jacksonville : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Jacksonville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Jacksonville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jacksonville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Jacksonville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lighthouse Point : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Maitland : Neurology Associates, PA

A clinical study for patients with Multiple Sclerosis

Maitland : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Maitland : Receptos Study Site 114 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Maitland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Melbourne : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Miami : Advanced Medical Pain Management & Research Clinic

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Miami : University of Miami Miller School of Medicine

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Miami : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Miami : University of Miami Miller School of Medicine

A Phase 2 clinical study for patients with Relapsing Remitting MS, Secondary Progressive MS or Primary Progressive MS

Miami : Teva Investigational Site 10316

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Miami : University of Miami Miller School of Medicine

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Miami Springs : Ocean Blue Medical Research Center Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Orlando : Compass Research

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Orlando : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

A clinical study for patients with Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Ormond Beach : Investigational Site Number 840007 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Ormond Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Ormond Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pompano Beach : Neurological Associates

A clinical study for patients with Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Pompano Beach : Receptos Study Site 124 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pompano Beach : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Ponte Vedra Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Port Charlotte : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Port Charlotte : Receptos Study Site 123 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Port Charlotte : Neurostudies, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Port Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Port Orange : Progressive Medical Research

A clinical study for patients with Multiple Sclerosis

Sarasota : Roskamp Institute

A clinical study for patients with Multiple Sclerosis

Sarasota : Investigational Site Number 840059 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Sarasota : Teva Investigational Site 10308

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarasota : Lovelace Scientific Resources, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Petersburg : Suncoast Neuroscience Associates, Inc

A clinical study for patients with Multiple Sclerosis

St. Petersburg : Suncoast Neuroscience Associates Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

St. Petersburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sunrise : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sunrise : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Tallahassee : AMO Corporation

A clinical study for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallahassee : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tampa : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Tampa : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Tampa : USF Carol and Frank Morsani Center for Advanced Healthcare

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tampa : Teva Investigational Site 10323

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tampa : University of South Florida

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tampa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Vero Beach : MS Center of Vero Beach

A clinical study for patients with Multiple Sclerosis

Vero Beach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Vero Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

West Palm Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

West Palm Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Weston : Cleveland Clinic Florida

A clinical study for patients with Multiple Sclerosis

Georgia

Atlanta : NeuroTrials Research

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Atlanta : Emory University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Atlanta : Shepherd Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Atlanta : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Atlanta : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Atlanta : Investigational Site Number 840002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Atlanta : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Atlanta : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Atlanta : Emory University

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Atlanta : Emory University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Decatur : Neurostudies

A clinical study for patients with Multiple Sclerosis

Macon : Investigational Site Number 840075 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Rome : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Savannah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hawaii

Honolulu : Leo Maher, MD

A clinical study for patients with Multiple Sclerosis

Illinois

Elk Grove Village : Alexian Brothers Hospital Network

A 6 month, randomized, active comparator, open-label, multi-center study to evaluate patient outcomes, safety and tolerability of Fingolimod (FTY720) 0.5mg/day in patients with relapsing remitting MS who are candidates for MS therapy change from previous disease modifying therapy (EPOC).

Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Champaign : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Chicago : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chicago : University of Chicago

Patients are needed to participate in a clinical research study evaluating Tysabri for the treatment of Multiple Sclerosis

Elk Grove Village : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Northwestern University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Flossmoor : South Suburban Neurology

A clinical study for patients with Multiple Sclerosis

Flossmoor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Flossmoor : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lake Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Northbrook : Receptos Study Site 113 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Northbrook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Peoria : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indiana

Anderson : Community Clinical Research Center

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis (PREFERMS)

Elkhart : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fort Wayne : Teva Investigational Site 10339

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Indianapolis : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Indianapolis : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indianapolis : Investigational Site Number 840001 Updated

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Merrillville : Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Iowa

Des Moines : Mercy Ruan Neurology Clinic Res Ct.

A clinical study for patients with Multiple Sclerosis

Des Moines : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

West Des Moines : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas

Kansas City : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Kansas City : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas City : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Lenexa : Mid America Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Lenexa : Midamerica Neuroscience Institute - Rowe Neurology Institute

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Lenexa : Rowe Neurology Institute

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Lenexa : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lenexa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lenexa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Lenexa : Rowe Neurology Institute

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Lenexa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Overland Park : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Topeka : Cotton O'Neil Clinical Research Institute

A clinical study for patients with Multiple Sclerosis

Topeka : Precise Clinical Research

A clinical study for patients with Multiple Sclerosis

Kentucky

Lexington : University of Kentucky Chandler Medical Center

Help us to make progress in Secondary Progressive MS

Lexington : Associates in Neurology

A clinical study for patients with Multiple Sclerosis

Lexington : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lexington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Lexington : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Louisville : Norton Healthcare, Inc.

A clinical study for patients with Multiple Sclerosis

Louisville : Norton Neurology MS Services

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Louisville : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Louisville : Investigational Site Number 840034 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Louisville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Louisville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Louisville : Norton Neurology MS Services

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Louisville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Louisiana

Baton Rouge : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hammond : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Orleans : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Maryland

Annapolis : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Baltimore : University of Maryland

A clinical study for patients with Multiple Sclerosis

Baltimore : Johns Hopkins

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Baltimore : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Baltimore : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Baltimore : Johns Hopkins

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Baltimore : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bethesda : Bethesda Neurology, LLC

A clinical study for patients with Multiple Sclerosis

Massachusetts

Boston : Caritas St. Elizabeth's Hospital

A clinical study for patients with Multiple Sclerosis

Boston : Skulpt, Inc

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Boston : Massachusetts General Hospital

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Boston : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Boston : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Boston : Teva Investigational Site 10338

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Boston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Boston : Brigham and Women's Hospital

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cambridge : Outcome Sciences, Inc

A clinical trial to evaluate treatments using Cladribine for patients with Multiple Sclerosis

Cambridge : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Cambridge : Registry participation is worldwide and not limited to this facility; facilities not yet active may enroll upon identification of a patient

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis or Exposure During Pregnancy

Lexington : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lexington : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milford : Milford Regional Medical Center

A clinical study for patients with Multiple Sclerosis

New Bedford : Research Site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Springfield : Springfield Neurology Associates, LLC

A clinical study for patients with Multiple Sclerosis

Springfield : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Springfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Worcester : Fallon Clinic at Worcester Medical Center

A clinical study for patients with Multiple Sclerosis

Worcester : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Worcester : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Worcester : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Michigan

Kalamazoo : Bronson Methodist Hospital

A 12-month, Prospective, Randomized, active-controlled, open-label study to Evaluate the patient retention of Fingolimod vs. approved first-line disease modifying therapies in adults who are in Early stages of treatment for Relapsing remitting multiple sclerosis (PREFERMS)

Ann Arbor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bingham Farms : Quest Research Institute

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Clinton Township : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Henry Ford Health System, Department of Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Detroit : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Research Site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

East Lansing : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Grand Rapids : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Muskegon : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Novi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Minnesota

Edina : Minneapolis Clinic of Neurology

A clinical study for patients with Multiple Sclerosis

Edina : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Golden Valley : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Minneapolis : Clinical Neuroscience Research Unit, University of Minnesota

A clinical trial seeking patients for a research study for the treatment of Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis or Progressive Relapsing Multiple Sclerosis

Missouri

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Children with and without Multiple Sclerosis or (MS) or Clinically Isolated Syndrome (CIS) are needed for a Washington University research study.

Chesterfield : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Columbia : University of Missouri Department of Physical Medicine and Rehabilitation

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Columbia : University of Missouri Department of Physical Medicine and Rehabilitation

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Kansas City : Saint Luke's Hospital

A clinical study for patients with Multiple Sclerosis

Kansas City : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Springfield : St.John's Research Institute, Inc

A clinical study for patients with Multiple Sclerosis

St. Louis : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

St. Louis : Investigational Site Number 840058 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St. Louis : Receptos Study Site 121 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Washington University School of Medicine in St Louis

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Montana

Great Falls : Benefis Physician Associates

A clinical study for patients with Multiple Sclerosis

Great Falls : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Great Falls : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Great Falls : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nebraska

Lincoln : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lincoln : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lincoln : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Nevada

Las Vegas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Hampshire

Lebanon : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

New Jersey

Freehold : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Freehold : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newark : UMDNJ

A clinical study for patients with Multiple Sclerosis

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Princeton : GE Healthcare

A Phase 1 clinical study for patients with Evaluate the Safety of GEH120714 (18F) Injection in Healthy Volunteers (HV) and Participants With rrMS.

Teaneck : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Mexico

Albuquerque : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Albuquerque : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New York

Mineola : Winthrop University Hospital Clinical Trials Center

Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

Albany : Neurological Associates of Albany, PC

A clinical study for patients with Multiple Sclerosis

Albany : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Albany : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Amherst : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Amherst : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bronx : Montefiore Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Buffalo : Buffalo Neuroimaging Analysis Center

A clinical research study for the treatment of Multiple Sclerosis

Buffalo : Buffalo Neuroimaging Analysis Center

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Buffalo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buffalo : University at Buffalo, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

East Setauket : Investigational Site Number 840100 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Latham : Empire Neurology, PC

A clinical study for patients with Multiple Sclerosis

Latham : Multiple Sclerosis Center of Northeastern New York

A clinical research study of incabotulinumtoxinA and Placebo for the treatment of Muscle Spasticity or Multiple Sclerosis

Latham : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Latham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Latham : Investigational Site Number 840001 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Secondary Progressive Multiple Sclerosis

New York : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

New York : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

New York : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New York : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study evaluating Acthar Gel for the treatment of Multiple Sclerosis

New York : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

New York : Cornell Medical College

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Patchogue : South Shore Neurologic Associates

A clinical study for patients with Multiple Sclerosis

Patchogue : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Patchogue : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Patchogue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Patchogue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Patchogue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Plainview : Island Neurological Associates

A clinical study for patients with Multiple Sclerosis

Plainview : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Plainview : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Plainview : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Rochester : University of Rochester Medical Center

A clinical study for patients with Multiple Sclerosis

Rochester : University of Rochester

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Rochester : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Lubiprostone and Placebo to evaluate Multiple Sclerosis or Constipation

Staten Island : Investigational Site Number 840091 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Stony Brook : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Stony Brook : Stony Brook University

A clinical trial to evaluate treatments using Mindfulness based stress reduction (MBSR) for patients with Multiple Sclerosis

Stony Brook : Stony Brook University

Patients are needed to participate in a clinical research study evaluating plasticity-based computerized cognitive remediation program and Gileyna for the treatment of Multiple Sclerosis, Cognitive Deficits or Gilenya Modifying Therapy for MS

Stony Brook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Stony Brook : University at Stony Brook, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Syracuse : SUNY Upstate Medical University

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Syracuse : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Syracuse : University at Upstate, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

White Plains : Burke Rehabilitation Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

White Plains : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

White Plains : Burke Rehabilitation Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

North Carolina

Charlotte : PMG Research of Charlotte

Have you been diagnosed with a relapsing form of Multiple Sclerosis?

Charlotte : PMG Research of Charlotte

Have you experienced greater disability from your Multiple Sclerosis (MS)?

Charlotte : PMG Research of Charlotte

Multiple Sclerosis (MS) Research Opportunity

Charlotte : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Concord : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Kannapolis : Duke University

The MURDOCK Study Community Registry and Biorepository Primary Progressive Multiple Sclerosis Cohort

Winston-Salem : PMG Research of Winston-Salem

Does your Multiple Sclerosis keep you from walking comfortably?

Winston-Salem : PMG Research of Winston-Salem

Have you been diagnosed with a relapsing form of Multiple Sclerosis?

Advance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Advance : Teva Investigational Site 10346

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Asheville : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Asheville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Chapel Hill : University of North Carolina at Chapel Hill Department of Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Chapel Hill : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlotte : The Neurological Institute, PA

A clinical study for patients with Multiple Sclerosis

Charlotte : Receptos Study Site 101 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Durham : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Durham : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hickory : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Hickory : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Raleigh : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Raleigh : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Raleigh : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Raleigh : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Winston-Salem : PMG Research of Winston-Salem

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Winston-Salem : Wake Forest University Health Sciences

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Winston-Salem : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Winston-Salem : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Winston-Salem : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Winston-Salem : Teva Investigational Site 10347

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Winston-Salem : PMG Research of Winston-Salem

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Winston-Salem : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

North Dakota

Bismarck : St. Alexius Medical Center

A research study for patients who have been diagnosed with multiple sclerosis

Grand Forks : Altru Health System/Altru Clinic-Main

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Grand Forks : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Ohio

Akron : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Akron : Receptos Study Site 107 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Akron : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Akron : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Akron : Neurology & Associates, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Akron : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bellevue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bellevue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Bellevue : Teva Investigational Site 10309

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bellevue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Canton : Investigational Site Number 840003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Cincinnati : University of Cincinnati, Department of Neurology

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cleveland : Rapid Medical Research Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Cleveland : Mellon Center for Multiple Sclerosis

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Cleveland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Cleveland : Receptos Study Site 104 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Cleveland : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Columbus : The Ohio State University Medical Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Columbus : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Columbus : Teva Investigational Site 10317

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Columbus : The Ohio State University Medical Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Ohio State University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Dayton : Neurology Specialists, Inc.

A clinical study for patients with Multiple Sclerosis

Dayton : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Dayton : Investigational Site Number 840009 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dayton : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Dayton : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dayton : Teva Investigational Site 10325

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dayton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Dayton : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Gahanna : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Toledo : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toledo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Uniontown : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Uniontown : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Oklahoma

Edmond : Retina Vitreous Center

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : Lynn Health Science Institute

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Oklahoma City : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Oklahoma City : Radiology Associates

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : Lynn Health Science Institute

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : OMRF MS Center of Excellence

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tulsa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tulsa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oregon

Corvallis : The Corvallis Clinic, P.C.

A clinical study for patients with Multiple Sclerosis

Medford : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Providence Multiple Sclerosis Center

A clinical study for patients with Multiple Sclerosis

Portland : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Portland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Portland : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Portland : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Pennsylvania

Abington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Abington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Abington : Abington Neurological Associates

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Abington : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Greensburg : Westmoreland Neurology

A clinical study for patients with Multiple Sclerosis

Greensburg : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Greensburg : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hershey : Penn State University College of Medicine/MS Hershey Medical Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Monaca : Investigational Site Number 840053 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Philadelphia : University of Pennsylvania Health System

A clinical study for patients with Multiple Sclerosis

Philadelphia : Thomas Jefferson University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Philadelphia : Investigational Site Number 840056 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Philadelphia : Receptos Study Site 109 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Philadelphia : Temple University School of Medicine

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pittsburgh : Research Protocol Management Solutions

A clinical study for patients with Multiple Sclerosis

Pittsburgh : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Pittsburgh : University of Pittsburgh

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tarentum : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Rhode Island

Cranston : Investigational Site Number 840072 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Providence : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

South Carolina

Greenville : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Greenville : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Greenville : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Spartanburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Spartanburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tennessee

Bristol : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Cordova : Neurology Clinic, P.C.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Cordova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cordova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Franklin : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Franklin : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Franklin : Teva Investigational Site 10324

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Knoxville : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Knoxville : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Knoxville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Knoxville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Knoxville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Teva Investigational Site 10318

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Vanderbilt University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tullahoma : Investigational Site Number 840035 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Texas

Dallas : Baylor Research Institute

Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

Austin : Future Search Trials of Neurology, LP

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Austin : Alkermes Investigational Site

A Phase 1 clinical study for patients with Multiple Sclerosis

Austin : Future Search Trials of Neurology, LP

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Dallas : University of Texas Southwestern

A clinical study for patients with Multiple Sclerosis

Dallas : Baylor Research Institute

A clinical study for patients with Multiple Sclerosis

Dallas : Investigational Site Number 840060 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dallas : UT Southwestern Medical Center

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Dallas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Dallas : University of Texas Southwestern Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Houston : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Houston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kingwood : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lubbock : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Round Rock : Central Texas Neurology Consultants, P.A.

A clinical study for patients with Multiple Sclerosis

Round Rock : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Round Rock : Investigational Site Number 840003 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Round Rock : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Round Rock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Round Rock : Research Site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

San Antonio : Innovative Clinical Trials, Bexar Diagnostic Medicine Assoc.

A clinical study for patients with Multiple Sclerosis

San Antonio : Investigational Site Number 840028 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

San Antonio : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

San Antonio : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

San Antonio : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Antonio : Research Site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Sherman : Texoma Neurology Associates

A clinical study for patients with Multiple Sclerosis

Sherman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Utah

Salt Lake City : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Salt Lake City : Rocky Mountain MS Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Secondary Progressive Multiple Sclerosis or Clinically Isolated Syndrome

Salt Lake City : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Salt Lake City : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Salt Lake City : Investigational Site Number 840002 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Salt Lake City : Rocky Mountain MS Research Group

A Phase 4 clinical study for patients with Relapsing Remitting Multiple Sclerosis

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Salt Lake City : University of Utah

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Vermont

Burlington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Virginia

Alexandria : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Alexandria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Charlottesville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : University of Virginia Charlottesville

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Henrico : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newport News : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Newport News : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport News : Teva Investigational Site 10330

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Norfolk : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Roanoke : Biogen Idec Investigative Site

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Roanoke : Investigational Site Number 840017 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Roanoke : Teva Investigational Site 10311

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roanoke : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Roanoke : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Vienna : Investigational Site Number 840054 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Washington

Issaquah : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kirkland : MS Center at Evergreen Health

A clinical research study for the treatment of Multiple Sclerosis

Kirkland : EvergreenHealth MS Center

Patients are needed to participate in a clinical research study evaluating Mirabegron and Placebo for the treatment of Multiple Sclerosis

Seattle : Swedish Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Seattle : Pacific Medical Centers

A clinical study for patients with Multiple Sclerosis

Seattle : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Seattle : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Seattle : Receptos Study Site 102 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Seattle : Teva Investigational Site 10335

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Seattle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Seattle : Swedish Medical Center - Seattle

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tacoma : MultiCare Research Institute

A clinical study for patients with Multiple Sclerosis

Tacoma : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tacoma : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tacoma : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

West Virginia

Morgantown : Investigational Site Number 840079 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Wisconsin

Milwaukee : Investigational Site Number 840112 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milwaukee : Wheaton Franciscan Heatlhcare-St. Francis Center of Neurological Disorders Outpatient Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Neenah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Waukesha : Cardiovascular & Neurosciences Research Institute, ProHealth Care, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Albania

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Algeria

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Argentina

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buenos aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Australia

Adelaide : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Auchenflower : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Bedford Park : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brisbane : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Brisbane Queensland : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Camperdown : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

East Gosford : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Geelong VIC : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kanwal : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Kogarah : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Kogarah : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Liverpool : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Melbourne : Nucleus Network - Centre for Clinical Studies

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Melbourne : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Nedlands : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

New Lambton Heights : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Parkville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Perth : Western Australian Neuroscience Research Institute

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Sydney : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Austria

Innsbruck : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Innsbruck : Teva Investigational Site 33013

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Klagenfurt : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Klagenfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Linz : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Linz : Investigational Site Number 040-001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Linz : Teva Investigational Site 33014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Salzburg : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

St. Polten : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Vienna : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Vienna : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Villach : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Investigational Site Number 040-002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Wien : Teva Investigational Site 33015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Wien : Teva Investigational Site 33016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belarus

Gomel : Receptos Study Site 904 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Grodno : Receptos Study Site 907 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Grodno : Teva Investigational Site 68013

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Receptos Study Site 903 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Minsk : Receptos Study Site 901 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Minsk : Receptos Study Site 902 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Minsk : Teva Investigational Site 68008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68012

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vitebsk : Receptos Study Site 905 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Vitebsk : Receptos Study Site 906 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Vitebsk : Teva Investigational Site 68011

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgium

Antwerpen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brabant Wallon : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brugge : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Brugge : Investigational Site Number 056002 Updated

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Brugge : Receptos Study Site 256 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Brugge : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brussels : Receptos Study Site 255 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Bruxelles : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bruxelles : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bruxelles : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Charleroi : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Edegem : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Edegem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hainaut : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Leuven : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Leuven : Receptos Study Site 253 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Liege : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Liège : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Limburg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Luxembourg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Melsbroek : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Melsbroek : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montegnée : Receptos Study Site 252 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Oost-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Ottignies : Receptos Study Site 254 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Overpelt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sijsele : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tinlot (Fraiture) : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

West-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Bosnia and Herzegovina

Mostar : Teva Investigational Site 69008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarajevo : Teva Investigational Site 69006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tuzla : Teva Investigational Site 69009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bulgaria

Pleven : Teva Investigational Site 59040

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Pleven : Teva Investigational Site 59039

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ruse : Teva Investigational Site 59061

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Shumen : Teva Investigational Site 59055

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Sofia : Receptos Study Site 456 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 452 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 451 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 455 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 457 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 454 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Receptos Study Site 453 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Teva Investigational Site 59058

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59041

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59038

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59059

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59057

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59045

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59042

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59048

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59050

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59054

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59052

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59063

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : For information on participating sites located in Bulgaria, please contact the Merck KGaA Communication Center Located in

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Varna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Varna : Teva Investigational Site 59046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59051

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59053

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vidin : Teva Investigational Site 59060

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Canada

Bracebridge : South Muskoka Medical Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Burlington : Central Contact

A clinical study for patients with Multiple Sclerosis

Burnaby : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Calgary : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Calgary : Multiple Sclerosis Clinic

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Calgary : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cambridge : Investigational Site Number 124006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Chicoutimi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Edmonton : University of Alberta

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Edmonton : Receptos Study Site 154 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Edmonton : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Edmonton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Gatineau : Clinique Neuro-Outaouais

Patients are needed to participate in a clinical research study of extended release fampridine and Placebo to evaluate Multiple Sclerosis

Greenfield Park : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Greenfield Park : Investigational Site Number 124001 Updated

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Greenfield Park : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Halifax : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Halifax : Dalhousie MS Research Unit

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Halifax : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Halifax : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Halifax : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Hamilton : St. Joseph Healthcare, Subject Recruitment Site

A Phase 1 clinical study for patients with Evaluate the Safety of GEH120714 (18F) Injection in Healthy Volunteers (HV) and Participants With rrMS.

Kingston : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

London : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

London : London Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Montreal : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Montreal : McGill University - MNI

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Montreal : Montreal Neurological Institute

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis-Relapsing-Remitting

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ottawa : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Ottawa : The Ottawa Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Ottawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Ottawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ottawa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Saint John : Private Community Clinic

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Saint John : Saint John Regional Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Saskatoon : Teva Investigational Site 11016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

St. John : Investigational Site Number 124007 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St. John's : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Toronto : Sunnybrook Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Toronto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Toronto : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vancouver : Vancouver Coastal Health: University of British Columbia Hospital

A clinical study for patients with Multiple Sclerosis

Vancouver : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Victoria : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Chile

Concepcion : Investigational Site Number 152003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Santiago : Investigational Site Number 152001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Santiago : Investigational Site Number 152005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Santiago : Multiple Sclerosis Centre, Pontificia Universidad Catolica de Chile Updated

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis or Multiple Sclerosis, Secondary Progressive

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

China

Nanjing : Nanjing University Medical College Affiliated Drum Tower Hospital

A clinical research study of human umbilical cord mesenchymal stem cells for the treatment of Progressive Multiple Sclerosis or Neuromyelitis Optica.

Croatia

Osijek : Teva Investigational Site 60010

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zagreb : Teva Investigational Site 60009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zagreb : For information on participating sites located in Croatia, please contact the Merck KGaA Communication Center Located in

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Czech Republic

Brno : Fakultni nemocnice u sv. Anny v Brne

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Brno : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Brno : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brno : Teva Investigational Site 54042

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Brno : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Brno : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Ceské Budesovice : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Havirov : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Havirov : Neurospol, s.r.o.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Havirov : Teva Investigational Site 54043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hradec Kralove : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Hradec Kralove : Fakultni nemocnice Hradec Kralove

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Hradec Kralove : Teva Investigational Site 54047

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hradec Kralové : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Jihlava : Nemocnice Jihlava

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Jihlava : Teva Investigational Site 54046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jihlava : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Olomouc : Teva Investigational Site 54044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Olomouc : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Ostrava : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Pardubice : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Pardubice : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Plzen : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague 10 : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague 4 : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague 5 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Praha : For information on participating sites located in Czech Republic, please contact the Merck KGaA Communication Center Located in

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Praha 5 : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Teplice : Krajska zdravotni, a.s. - Nemocnice Teplice, o.z.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Teplice : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Teplice : Teva Investigational Site 54048

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Teplice : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Zlín : Research site Updated

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Denmark

Aarhus : Sport Science, Department of Public Health, Aarhus University

Patients are needed to participate in a clinical research study evaluating Aerobic exercise for the treatment of Multiple Sclerosis

Esbjerg : Research Site

A clinical trial to evaluate treatments for patients with Exercise

Odense : Odense University Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Vejle : Research Site

A clinical trial to evaluate treatments for patients with Exercise

Egypt

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Estonia

Paernu : Teva Investigational Site 55005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallinn : Teva Investigational Site 55006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Teva Investigational Site 55008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Investigational Site Number 233001 Updated

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Tartu : Teva Investigational Site 55007

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Finland

Hämeenlinna : Investigational Site Number 246004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Helsinki : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Kuopio : Investigational Site Number 246005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Oulu : Investigational Site Number 246006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Turku : Investigational Site Number 246003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Turku : Investigational Site Number 246001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Turku : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

France

Agen Cedex : Investigational Site Number 250002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Aix En Provence : Investigational Site Number 250003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Albi : Investigational Site Number 250004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Amiens Cedex 1 : Investigational Site Number 250005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bayonne : Investigational Site Number 250006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Besancon cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bordeaux : Service de Neurologie - Pôle des Neurosciences Cliniques, CHU de Bordeaux.

A clinical study for patients with Multiple Sclerosis or Cognitive Rehabilitation

Bordeaux : Investigational Site Number 250007 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bordeaux : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bordeaux : Hopital Pellegrin

A Phase 3 clinical study for patients with Multiple Sclerosis

Bordeaux Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Caen : Investigational Site Number 250008 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Caen : Hopital de la cote de Nacre

A Phase 3 clinical study for patients with Multiple Sclerosis

CAEN Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

CAHORS Cedex 9 : Investigational Site Number 250009 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Chambery : Investigational Site Number 250011 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Clermont Ferrand : Hopital Gabriel Montpied

A Phase 3 clinical study for patients with Multiple Sclerosis

Clermont-Ferrand Cedex 1 : Teva Investigational Site 35075

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Colmar : Investigational Site Number 250012 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dijon : Investigational Site Number 250001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dijon : Hopital general du Bocage

A Phase 3 clinical study for patients with Multiple Sclerosis

Dijon : Teva Investigational Site 35077

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

GRENOBLE cedex : Investigational Site Number 250015 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

La Roche sur Yon : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Le Chesnay Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Le Kremlin Bicetre : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Le Kremlin Bicêtre : Investigational Site Number 250001 Updated

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Le Mans Cedex 9 : Investigational Site Number 250017 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lille : CHRU de Lille

A Phase 3 clinical study for patients with Multiple Sclerosis

Lille : Teva Investigational Site 35073

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lille Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Lille Cedex : Investigational Site Number 250018 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lille Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Lille Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Limoges cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Limoges Cedex : Investigational Site Number 250019 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lyon : Hopital Pierre Wertheimer

A Phase 3 clinical study for patients with Multiple Sclerosis

Lyon cedex 04 : Teva Investigational Site 35076

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marseille : Investigational Site Number 250021 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Marseille : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Marseille : Hopital de la Timone

A Phase 3 clinical study for patients with Multiple Sclerosis

Marseille : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Metz-Tessy : Investigational Site Number 250022 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Montbeliard : Investigational Site Number 250023 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Montpellier : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montpellier : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Montpellier : Hopital Gui de Chauliac

A Phase 3 clinical study for patients with Multiple Sclerosis

Montpellier : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

MONTPELLIER Cedex 5 : Investigational Site Number 250024 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Mulhouse : Investigational Site Number 250025 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nancy : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nancy : Investigational Site Number 250026 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nancy : Hopital Central

A Phase 3 clinical study for patients with Multiple Sclerosis

Nancy : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nantes : Investigational Site Number 250027 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nantes : Hopital Nord Laennec

A Phase 3 clinical study for patients with Multiple Sclerosis

Nantes cedex 1 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nice : Hopital Pasteur

A Phase 3 clinical study for patients with Multiple Sclerosis

Nimes : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nimes : Investigational Site Number 250028 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nîmes : Teva Investigational Site 35079

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Paris : Fondation Rothschild

A Phase 3 clinical study for patients with Multiple Sclerosis

Paris : Groupe hospitalier la Pitie-Salpetriere

A Phase 3 clinical study for patients with Multiple Sclerosis

Paris : Centre hospitalier national d'ophtalmologie des Quinze Vingts

A Phase 3 clinical study for patients with Multiple Sclerosis

PARIS Cedex 13 : Investigational Site Number 250016 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Paris Cedex 13 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

PARIS Cedex 20 : Investigational Site Number 250029 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Pau : Investigational Site Number 250043 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Poissy : Centre hospitalier Intercommunal Poissy/Saint-Germain-en-Laye

A Phase 3 clinical study for patients with Multiple Sclerosis

Poitiers cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Quimper : Investigational Site Number 250031 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Reims : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Reims : Investigational Site Number 250032 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Reims : Hopital Maison Blanche

A Phase 3 clinical study for patients with Multiple Sclerosis

Rennes : Hopital Pontchaillou

A Phase 3 clinical study for patients with Multiple Sclerosis

Rennes : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rennes cedex 09 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Rouen : Investigational Site Number 250033 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Rouen Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

St Germain En Laye : Investigational Site Number 250030 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St Herblain : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Strasbourg : Investigational Site Number 250035 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Strasbourg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Strasbourg : Hopital de Hautepierre

A Phase 3 clinical study for patients with Multiple Sclerosis

Strasbourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Strasbourg Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Toulouse : Investigational Site Number 250037 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Toulouse : Hopital Purpan

A Phase 3 clinical study for patients with Multiple Sclerosis

Toulouse cedex 1 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Tours : Investigational Site Number 250038 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Valence Cedex 9 : Investigational Site Number 250039 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Valenciennes : Investigational Site Number 250040 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

VICHY Cedex : Investigational Site Number 250013 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Georgia

Tbilisi : Receptos Study Site 301 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Tbilisi : Receptos Study Site 302 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Tbilisi : Receptos Study Site 303 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Tbilisi : Teva Investigational Site 81016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81018

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81019

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81017

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Germany

Aachen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aachen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aalen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aalen-Wasseralfingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Abensberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Achim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aichach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenholz-Stift : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Alzenau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Andernach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Asbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aschaffenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Aschaffenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Augsburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Honnef : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Krozingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Mergentheim : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bad Mergentheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Mergentheim : Teva Investigational Site 32199

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bad Saarow : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Wildbad : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bamberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bayreuth : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bayreuth : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bergisch Gladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bergisch-Gladbach : Investigational Site Number 276001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Berlin : Investigational Site Number 276003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Teva Investigational Site 32174

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32176

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32198

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32200

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32186

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bielefeld : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Böblingen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Böblingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bochum : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Teva Investigational Site 32177

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bochum : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis or Pregnancy

Bochum : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Bogen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bonn : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bonn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bonn : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Borna : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bottrop : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Braunschweig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bremen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bruchsal : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Buchholz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Buchholz in der Nordheide : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Butzbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Celle : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Chemnitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck KGaA Communication Center

A Phase 2 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck KGaA Communication Center

Patients are needed to participate in a clinical research study of Rebif® to evaluate Multiple Sclerosis, Relapsing-Remitting

Darmstadt : Please contact the Merck Communications Service for Recruiting locations

Patients are needed to participate in a clinical research study of Technical support for the RebiSmart™ device and Patient support program (MinSupport Plus) to evaluate Multiple Sclerosis or Relapsing-Remitting

Delbrueck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Teva Investigational Site 32193

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Duesseldorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Duesseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Duesseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düren : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Heinrich Heine Universität Düsseldorf

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eisenach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eltville : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emmendingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erbach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Erbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erfurt : Teva Investigational Site 32189

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Erlangen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Erlangen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Erlangen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eschwege : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Flensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Freiburg : Investigational Site Number 276004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Freiburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Freiburg : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Friedrichshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Geldern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelnhausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelsenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gera : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gießen : Teva Investigational Site 32203

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gilching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gladenbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Goettingen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Goettingen : Teva Investigational Site 32202

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Göttingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greifswald : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Greifswald : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Grevenbroich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Griesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gummersbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Haar : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hagen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle (Saale) : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle (Saale) : Teva Investigational Site 32196

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Halle/S. : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Heidelberg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Heidenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hennigsdorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Herdecke : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hildesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hoppegarten : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ibbenbüren : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ibbenbüren : Teva Investigational Site 32175

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Idar-Oberstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Teva Investigational Site 32201

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Juelich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaiserslautern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaltenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kamen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kandel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Karlstadt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kassel : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kassel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kiel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Klingenmünster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koeln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koln : Teva Investigational Site 32183

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Königsbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Korbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Landshut : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lappersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Teva Investigational Site 32190

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Leverkusen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lohr am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lübeck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lüneburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lutherstadt Eisleben : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Teva Investigational Site 32185

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Mainz : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Many Locations : Updated

A clinical study for patients with Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaferon, BAY 86-5046) to evaluate Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Meisenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mittweida : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mosbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenchen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mülheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

München : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Münster : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Münster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nagold : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuberg : Research Site

A clinical research study for the treatment of Multiple Sclerosis

Neuburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Neuburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuruppin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neusäß : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neu-Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nordhausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nürnberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Oldenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg i. Holstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrueck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ostfildern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Pforzheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Potsdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Potsdam : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Prien : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Prien : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Quakenbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Querfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ravensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Recklinghausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Regensburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Regensburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Regensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Remscheid : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rostock : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Rostock : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rostock : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rostock : Teva Investigational Site 32191

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Rüdersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Saarbrücken : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Schwalmstadt-Treysa : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Schwendi : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Schwerin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Siegen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Siegen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Singen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Sinsheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Solingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

St. Ingbert : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stade : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Stade : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stadtroda : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Stadtroda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stralsund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Telgte : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Teupitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Teupitz : Teva Investigational Site 32194

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Troisdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Tübingen : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tübingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Ulm : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Teva Investigational Site 32173

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Unterhaching : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Unterhaching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wasserburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wendlingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wermsdorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Wermsdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Westerstede : Teva Investigational Site 32188

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Westerstede/Oldenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wolfratshausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wuppertal : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Würzburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Würzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Zwickau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greece

Athens : Investigational Site Number 300001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Athens : Investigational Site Number 300002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Athens : Receptos Study Site 551 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Athens : Receptos Study Site 553 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Athens : Receptos Study Site 552 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Athens : Receptos Study Site 554 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Athens : Teva Investigational Site 63027

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Athens : Teva Investigational Site 63024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Athens - GR : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chaidari : Teva Investigational Site 63029

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Heraklion Crete : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Larissa : Investigational Site Number 300005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Larissa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Thessaloniki : Investigational Site Number 300004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Thessaloniki : Receptos Study Site 555 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Thessaloniki : Receptos Study Site 557 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Thessaloniki : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Thessaloniki : Teva Investigational Site 63025

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Thessaloniki : Teva Investigational Site 63028

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hungary

Balassagyarmat : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Budapest : Receptos Study Site 356 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Budapest : Receptos Study Site 352 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : For information on participating sites located in Hungary, please contact the Merck KGaA Communication Center Located in

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Debrecen : Teva Investigational Site 51043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Eger : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Esztergom : Receptos Study Site 354 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Esztergom : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gyor : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kaposvar : Teva Investigational Site 51044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Miskolc : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Miskolc : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nyiregyhaza : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nyíregyháza : Receptos Study Site 351 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Szeged : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Szekesfehervar : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Szekesfehervar : Receptos Study Site 355 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Veszprem : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Veszprem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ireland

Cork : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Dublin : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate, Acetylsalicylic acid and ASA-Placebo for the treatment of Relapsing-Remitting Multiple Sclerosis

Dublin : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Dublin 4 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dublin 9 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Israel

Haifa : Carmel Medical Center Updated

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Haifa : Teva Investigational Site 80023

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Haifa : Teva Investigational Site 80024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jerusalem : Investigational Site Number 376001 Updated

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ramat Gan : Teva Investigational Site 80020

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tel Aviv : TASMC Updated

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Tel Aviv : RedHill MS Clinical Trial Site 002

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Tel-Aviv : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tel-Aviv : Teva Investigational Site 80021

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zefat (Safed) : RedHill MS Clinical Trials Site 001

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Italy

Ancona : Investigational Site Number 380008 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bari : Investigational Site Number 380009 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bologna : Teva Investigational Site 30037

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Caltanissetta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Catania : Receptos Study Site 654 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Catania : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Cefalu : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Cefalù : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Cefalù : Receptos Study Site 653 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Cefalù : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cefalù (Palermo) : Teva Investigational Site 30030

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chieti : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Chieti : Teva Investigational Site 30032

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Como : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Empoli (FI) : Teva Investigational Site 30031

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Firenze : Teva Investigational Site 30024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gallarate : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Gallarate : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Gallarate (VA) : Investigational Site Number 380002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Gallarate (Varese) : Teva Investigational Site 30029

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Genova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Messina : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Milan : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Milano : Investigational Site Number 380001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milano : Investigational Site Number 380004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Milano : Receptos Study Site 655 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Milano : Receptos Study Site 652 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Milano : Teva Investigational Site 30023

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Milano : Teva Investigational Site 30039

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Modena : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Montichiari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Montichiari : Receptos Study Site 659 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Napoli : Investigational Site Number 380006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Napoli : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Napoli : Receptos Study Site 656 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Napoli : Teva Investigational Site 30034

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Orbassano (TO) : Investigational Site Number 380005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Padova : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Pavia : Receptos Study Site 658 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Pisa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Roma : Teva Investigational Site 30028

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30035

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30026

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30025

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : For information on participating sites located in Italy, please contact the Merck KGaA Communication Center Located in

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Rome : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Siena : Receptos Study Site 657 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Verona : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Japan

Asahikawa-shi : NHO Asahikawa Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Bunkyo-ku : Juntendo University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Chiba : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Chiba-shi : Chiba University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fuchu : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Fukuoka-shi : Kyushu University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fukuoka-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kahoku-gun : Kanazawa Medical University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kawagoe-shi : Saitama Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kawagoe-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kobe-shi : Kobe University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kodaira-shi : National Center Hospital, NCNP

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kodaira-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kyoto-shi : Kyoto University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kyoto-shi : NHO Utano Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Morioka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Morioka-shi : Iwate Medical University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Niigata : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Niigata-shi : Niigata University Medical & Dental Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Osaka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Osakasayama-shi : Kinki University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Osaka-shi : Irino Clinic, Inc.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ota-ku : Tokyotohokeniryokosya Ebara Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sapporo-shi : NHO Hokkaido Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo-shi : CEReS Sapporo Neurology Clinic

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo-Shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sendai : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sendai-shi : Tohoku University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Department of Neurosurgery, Tokyo Women's Medical University

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Keio University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Suita-shi : Osaka University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Tokorozawa-shi : National Defense Medical College Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Tokyo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Toon-shi : Ehime University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Toon-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Tsukuba-shi : Tsukuba University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ube-shi : Yamaguchi University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Yachiyo-shi : Tokyo Womens Medical University Yachiyo Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Yachiyo-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Yamaguchi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Yokohama-shi : Yokohama City University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kazakhstan

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Korea, Republic of

Daegu : Yeungnam University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Goyang, GYEONGGI-DO : Teva Investigational Site 87001

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gyeonggi-do : National Cancer Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Samsung Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Asan Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Korea University Anam Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Seoul National University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Teva Investigational Site 87002

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Latvia

Riga : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Teva Investigational Site 56005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Riga : Teva Investigational Site 56006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lebanon

Beirut : Investigational Site Number 422001 Updated

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Lithuania

Kaunas : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Kaunas : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Klaipeda : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vilnius : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Macedonia, The Former Yugoslav Republic of

Skopje : Teva Investigational Site 65012

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65011

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65010

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Mexico

Aguascalientes : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Mexico : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

México : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Mexico City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monterrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monterrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Luis Potosi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Moldova, Republic of

Chisinau : Receptos Study Site 933 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Chisinau : Teva Investigational Site 70008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Montenegro

Podgorica : Teva Investigational Site 66002

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Netherlands

Amsterdam : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Amsterdam : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Amsterdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Amsterdam : VUmc, PET and neurology clinical research unit

First in Human, Double-blind, Placebo- and Active Comparator-controlled Study of 2B3-201 in Healthy Male Subjects

Breda : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Breda : Investigational Site Number 528001 Updated

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Breda : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Breda : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Breda : Amphia Ziekenhuis

Patients are needed to participate in a clinical research study evaluating glatiramer acetate for the treatment of Multiple Sclerosis

Eindhoven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gouda : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Hoorn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leiden : Centre for Human Drug Research (CHDR)

First in Human, Double-blind, Placebo- and Active Comparator-controlled Study of 2B3-201 in Healthy Male Subjects

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Rotterdam : Investigational Site Number 528002 Updated

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Sittard : Maasland Ziekenhuis

Patients are needed to participate in a clinical research study evaluating glatiramer acetate for the treatment of Multiple Sclerosis

Sittard-Geleen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Sittard-Geleen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tilburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tilburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Norway

Bergen : Investigational Site Number 578002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Molde : Molde Hospital

A clinical research study for the treatment of Multiple Sclerosis

Oslo : Investigational Site Number 578001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Stavanger : Stavanger University Hospital

A clinical research study for the treatment of Multiple Sclerosis

Panama

Panama City : Stem Cell Institute

Patients are needed to participate in a clinical research study evaluating Umbilical cord mesenchymal stem cells for the treatment of Multiple Sclerosis

Peru

Jesus Maria : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Poland

Bialystok : Receptos Study Site 401 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Bialystok : Teva Investigational Site 53071

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bydgoszcz : Receptos Study Site 423 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Czeladz : Receptos Study Site 406 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Czestochowa : Teva Investigational Site 53084

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Copernicus Podmiot Leczniczy Sp. z o.o.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Gdansk : Receptos Study Site 405 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Gdansk : Receptos Study Site 425 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Gdansk : Teva Investigational Site 53067

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Teva Investigational Site 53069

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Teva Investigational Site 53083

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Grodzisk Mazowiecki : Teva Investigational Site 53078

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Grudziadz : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Grudziadz : Teva Investigational Site 53085

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Nzoz Novo-Med

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Katowice : M.A. - LEK A.M.Maciejowscy SC.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Katowice : Receptos Study Site 407 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Katowice : Receptos Study Site 427 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Katowice : Receptos Study Site 417 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Katowice : Receptos Study Site 426 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Katowice : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Katowice : Teva Investigational Site 53073

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53070

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53074

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53080

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Kielce : Receptos Study Site 424 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Kielce : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Konskie : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Konskie : Teva Investigational Site 53064

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Konstancin-Jeziorna : Receptos Study Site 404 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Konstancin-Jeziorna : Teva Investigational Site 53065

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Koscierzyna : Teva Investigational Site 53072

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Krakow : MCD Medical

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Krakow : Receptos Study Site 414 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Krakow : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lodz : Receptos Study Site 411 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Lodz : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lublin : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Lublin : Receptos Study Site 412 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Lublin : Receptos Study Site 420 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Many Locations : Updated

A clinical trial to evaluate treatments using Interferon beta-1b (Betaseron, BAY86-5046) for patients with Multiple Sclerosis

Olsztyn : Receptos Study Site 415 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Olsztyn : Receptos Study Site 402 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Olsztyn : Teva Investigational Site 53079

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Plewiska : Neurologiczny NZOZ Centrum Leczenia SM

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Plewiska : Receptos Study Site 421 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Poznan : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Poznan : Receptos Study Site 408 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Poznan : Receptos Study Site 418 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Poznan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Poznan / Plewiska : Teva Investigational Site 53068

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Szczecin : Receptos Study Site 419 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Szczecin : Teva Investigational Site 53076

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Warszawa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Warszawa : Receptos Study Site 413 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Warszawa : Receptos Study Site 422 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Warszawa : Receptos Study Site 403 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Warszawa : Receptos Study Site 410 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Warszawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Portugal

Amadora : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Amadora : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Braga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Coimbra : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Guimarães : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Lisboa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Porto : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Puerto Rico

Guaynabo : Caribbean Center for Clinical Research, Inc.

A clinical study for patients with Multiple Sclerosis

Guaynabo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Romania

Balotesti : Teva Investigational Site 52045

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Brasov : Receptos Study Site 503 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Bucharest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Bucharest : Receptos Study Site 504 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Bucharest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bucharest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bucharest : Teva Investigational Site 52041

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Teva Investigational Site 52050

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Teva Investigational Site 52034

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Teva Investigational Site 52037

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Campulung : Receptos Study Site 502 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Cluj Napoca : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cluj-Napoca : Receptos Study Site 501 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Cluj-Napoca : Teva Investigational Site 52040

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cluj-Napoca : Teva Investigational Site 52036

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Constanta : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Constanta : Teva Investigational Site 52044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Constanta : Teva Investigational Site 52038

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Craiova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dolj : Teva Investigational Site 52048

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hunedoara : Teva Investigational Site 52049

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Iasi : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Iasi : Teva Investigational Site 52042

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Oradea : Teva Investigational Site 52039

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Piatra-Neamt : Teva Investigational Site 52047

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sibiu : Receptos Study Site 505 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sibiu : Teva Investigational Site 52046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Suceava : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Targu Mures : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tg. Mures : Teva Investigational Site 52035

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Timisoara : Receptos Study Site 506 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Timisoara : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Timisoara : Teva Investigational Site 52043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Russian Federation

Barnaul : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Barnaul : Teva Investigational Site 50130

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chelyabinsk : Receptos Study Site 701 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Chelyabinsk : Teva Investigational Site 50129

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Kazan : Receptos Study Site 704 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Kazan : Receptos Study Site 713 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Kazan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kazan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Moscow : Receptos Study Site 709 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Moscow : Receptos Study Site 712 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Moscow : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Moscow : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Moscow : Teva Investigational Site 50124

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50133

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50146

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50147

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhny Novgorod : Teva Investigational Site 50141

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhny Novgorod : Teva Investigational Site 50128

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhny Novgorod : Teva Investigational Site 50131

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Novosibirsk : Receptos Study Site 703 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Novosibirsk : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Perm : Receptos Study Site 710 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Perm : Teva Investigational Site 50127

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Rostov-on-Don : Teva Investigational Site 50143

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint Petersburg : Teva Investigational Site 50140

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint Petersburg : Teva Investigational Site 50126

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint-Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Samara : Receptos Study Site 716 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Samara : Teva Investigational Site 50138

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saransk : Receptos Study Site 715 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Saratov : Receptos Study Site 714 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Saratov : Teva Investigational Site 50135

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Smolensk : Receptos Study Site 707 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Smolensk : Teva Investigational Site 50136

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

St. Petersburg : Receptos Study Site 708 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St. Petersburg : Teva Investigational Site 50137

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tomsk : Teva Investigational Site 50125

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tyumen : Receptos Study Site 717 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Tyumen : Teva Investigational Site 50139

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ufa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ufa : Teva Investigational Site 50134

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Volgograd : Teva Investigational Site 50132

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Yaroslavl : Receptos Study Site 711 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Yaroslavl : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Yaroslavl : Teva Investigational Site 50142

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saudi Arabia

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Serbia

Belgrade : Receptos Study Site 603 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Belgrade : Receptos Study Site 601 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Belgrade : Receptos Study Site 602 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Belgrade : Receptos Study Site 604 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Belgrade : Teva Investigational Site 61024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgrade : Teva Investigational Site 61027

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgrade : Teva Investigational Site 61025

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cacak : Teva Investigational Site 61018

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Kragujevac : Receptos Study Site 605 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Kragujevac : Teva Investigational Site 61015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nis : Receptos Study Site 606 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Nis : Teva Investigational Site 61014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sombar : Teva Investigational Site 61019

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Subotica : Teva Investigational Site 61016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Uzice : Teva Investigational Site 61017

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Valjevo : Teva Investigational Site 61022

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zrenjanin : Teva Investigational Site 61021

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Slovakia

Banska Bystrica : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bratislava : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bratislava : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bratislava : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hlohovec : Teva Investigational Site 62012

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lucenec : Receptos Study Site 942 Updated

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Martin : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nitra : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nitra : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Presov : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis